期刊文献+

移动健康医疗在改善心血管疾病患者依从性中的作用 被引量:8

Effect of Mobile Health on Improving Adherence in Cardiovascular Disease Patients
下载PDF
导出
摘要 心血管疾病是全球发病率、病死率最高的疾病,而影响其预后的一个重要阻碍在于用药依从性不佳。目前,已经出现了各种方式以改善患者依从性,随着移动科技的进展,移动健康医疗正在蓬勃发展并对患者依从性带来了影响。现就移动健康医疗在心血管疾病领域中,对患者依从性影响的研究进展做一综述。 Cardiovascular disease has the highest incidence of morbidity and mortality worldwide,and an key obstacle to its outcome is poor medication compliance. There have been variety of methods to improve patient compliance,with the progress of mobile technology,the mobile health is booming and has an impact on patient compliance. The paper reviews several research studies to illustrate the effect of this new technology on patient compliance with cardiovascular disease.
出处 《心血管病学进展》 CAS 2017年第6期635-639,共5页 Advances in Cardiovascular Diseases
关键词 心血管疾病 移动健康医疗 依从性 Cardiovascular disease Mobile health Compliance
  • 相关文献

参考文献1

二级参考文献24

  • 1Jiang G,Wang D, Li W,et al. Coronary heart disease mortality in China: age, gender, and urban-rural gaps during epidemiological transition [ J ]. Rev Panam Salud Publica,2012,31 (4) :317-324.
  • 2Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary Preven- tion and Risk Reduction Therapy for Patients with Coronary and other Athero- sclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation [ J ]. Circulation, 2011,124(22) :2458-2473.
  • 3Choudhry NK, Glynn R J, Avoru J, et al. Untangling the relationship between medication adherence and post-myocardial infarction outcomes : medication ad- herence and clinical outcomes[ J]. Am Heart J ,2014,167( 1 ) :51-58.
  • 4Ho PM, Bryson CL, Rumsfeld JS. Medication adherence :its importance in car- diovascular outcomes [ J ]. Circulation,2009,119 ( 23 ) : 3028 -3035.
  • 5Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular thera- py : a meta-analysis of prevalence and clinical consequences [ J ]. Eur Heart J, 2013,34(38) : 2940-2948.
  • 6Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for car- diovascular disease in the community in high-income, middle-income, and low- income countries (the PURE study) :a prospective epidemiological survey [ J ]. Lancet,20l 1,378 (9798) : 1231-1243.
  • 7Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovas- cular disease: meta-analysis on 376 162 patients [ J ]. Am J Med, 2012, 125 (9) :882-887.
  • 8Rossi E,Perman G, Michelangelo H, et al. Medication adherence to secondary prevention for coronary artery disease [ J ]. Medicina ( B Aires), 2014,74 ( 2 ) : 99-103.
  • 9Valle JA, Ho PM. Medication adherence in secondary prevention post-myocardi- al infarction[J]. Curr Treat Options Cardiovasc Med,2014,16(12) :349.
  • 10Wroe AL. Intentional and Unintentional nonadherence : a study of decision-mak- ing[J]. J Behav Med,2002,25(4) :355-372.

共引文献5

同被引文献78

引证文献8

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部